© 2020 MJH Life Sciences and Cancer Network. All rights reserved.
© 2020 MJH Life Sciences™ and Cancer Network. All rights reserved.
June 19, 2018
In PREOPANC, the 2-year survival rate was significantly higher for patients who received neoadjuvant chemoradiotherapy vs standard care.
June 14, 2018
Six months of maintenance chemotherapy improved OS in children with high-risk rhabdomyosarcoma.
Compared with gemcitabine, mFOLFIRINOX improved outcomes for all endpoints when used in the adjuvant setting.
February 15, 2018
Do you know how many new cases of ovarian cancer are expected in 2018? And could long-term oral contraceptive use be a chemopreventive for certain gynecologic cancers? Test your knowledge in our latest quiz.